This report contains market size and forecasts of Recombinant Antibodies (rAbs) in global, including the following market information:
Global Recombinant Antibodies (rAbs) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Antibodies (rAbs) Market Sales, 2017-2022, 2023-2028, (L)
Global top five Recombinant Antibodies (rAbs) companies in 2021 (%)
The global Recombinant Antibodies (rAbs) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rabbit Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Antibodies (rAbs) include Abcam, Abeomics, Abnova Corporation, Absolute Antibody, Activity Signaling, AIVD Biotech, Bio X Cell, BioLegend and Bio-Rad, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Antibodies (rAbs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Antibodies (rAbs) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (L)
Global Recombinant Antibodies (rAbs) Market Segment Percentages, by Type, 2021 (%)
Rabbit
Mouse
Goat
Others
Global Recombinant Antibodies (rAbs) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (L)
Global Recombinant Antibodies (rAbs) Market Segment Percentages, by Application, 2021 (%)
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology
Research Institutes
Others
Global Recombinant Antibodies (rAbs) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (L)
Global Recombinant Antibodies (rAbs) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Antibodies (rAbs) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Antibodies (rAbs) revenues share in global market, 2021 (%)
Key companies Recombinant Antibodies (rAbs) sales in global market, 2017-2022 (Estimated), (L)
Key companies Recombinant Antibodies (rAbs) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abcam
Abeomics
Abnova Corporation
Absolute Antibody
Activity Signaling
AIVD Biotech
Bio X Cell
BioLegend
Bio-Rad
Bon Opus Biosciences
Creative Biolabs
Creative Diagnostics
Enzo Life Sciences, Inc.
GRP GmbH
HUABIO
Miltenyi Biotec
NSJ Bioreagents
PROGEN
RevMab Biosciences USA, Inc.
Signalway Antibody LLC